HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Ginkgo Bioworks (DNA) Investors with $150K+ Losses to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations
October 18, 2021 19:25 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ginkgo Bioworks (DNA) Investors to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations
October 11, 2021 09:31 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Ginkgo Bioworks (DNA) Investors to Contact Firm’s Attorneys Now, Firm Investigating Possible Securities Law Violations
October 06, 2021 17:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) investors with significant losses to submit your losses now. Visit:...